Logo

908 Devices: Kevin Hrusovsky

Nov 02, 2020

908 Devices, a company specializing in handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Kevin Hrusovsky as chairman of its board of directors. Hrusovsky has served on the company's board since 2013. He is currently chairman, CEO, and president of Quanterix, and is the founder of Powering Precision Health, a nonprofit global think tank composed of medical, research, and financial experts.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.